Omeros (OMER) Tops Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. DOX
8. INSP
9. HNGE
10. AMD

Go back to Omeros (OMER) Tops Q2 EPS by 11c

Omeros Corporation Reports Second Quarter 2021 Financial Results

August 9, 2021 4:02 PM EDT

Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders, today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2021, which include:

OMIDRIA revenues for the second quarter of 2021 were $28.8 million compared to $21.1 million in the first... More